Europe

Sweden to invest $320 million in life sciences

Wednesday, September 12, 2012 10:41 AM

A delegation of four ministers from the Swedish government, led by the Prime Minister Fredrik Reinfeldt, confirmed the country's largest ever investment in life sciences as a key element of the ruling coalition's autumn budget and research and innovation bill.

More... »

F2G completes $30M financing round for anti-fungal compounds

Thursday, September 6, 2012 07:48 AM

More... »

CLC bio acquires Molegro

Wednesday, September 5, 2012 10:55 AM

CLC bio, a provider of bioinformatics solutions, has acquired Molegro, a specialized software company focusing on molecular docking, including prediction and analysis of protein-ligand interactions, screening of compound databases for activities against a receptor and determination of molecule similarity.

More... »

Merck, employee representatives agree on efficiency plan for Germany

Wednesday, September 5, 2012 10:47 AM

Merck, a global healthcare company based in Darmstadt, Germany, has signed an agreement with employee representatives on an efficiency plan for the company's Germany operations.

More... »

Icon forms partnership with University College Dublin

Wednesday, September 5, 2012 10:13 AM

Icon,a global provider of outsourced development services, has entered into a strategic partnership with University College Dublin (UCD), Ireland’s largest third-level institution.

More... »

FDA approves new treatment for severe neutropenia in cancer patients

Tuesday, September 4, 2012 08:30 AM

The FDA has approved Sicor Biotech’s tbo-filgrastim to reduce the time certain patients receiving cancer chemotherapy experience severe neutropenia, a decrease in infection-fighting white blood cells called neutrophils.

More... »

U.K. general public has fundamental misunderstanding of cost and value of medicines

Monday, September 3, 2012 08:00 AM

A new survey commissioned by the ABPI, has revealed that the British public misunderstands the cost and value of medicines in the U.K.

More... »

EMD Millipore to acquire Biochrom

Thursday, August 23, 2012 09:54 AM

EMD Millipore, the life science division of Merck of Darmstadt, Germany, has decided to acquire Biochrom, a cell culture media specialist of Berlin, Germany. The closing price was not disclosed.

More... »

Shire joins ABPI

Tuesday, August 21, 2012 09:56 AM

Specialty biopharmaceutical company Shire has joined the Association of the British Pharmaceutical Industry (ABPI) as a full member.

More... »

Astellas Pharma Europe appoints Wood as senior director, market access

Monday, August 20, 2012 03:21 PM

Astellas Pharma Europe, the European subsidiary of Tokyo-based Astellas Pharma, has appointed Dr, Susan Wood as senior director, market access.

More... »